

BioCentury This Week
BioCentury
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Episodes
Mentioned books

Jun 16, 2020 • 17min
Ep. 10 - EUAs, ACTIV & M&A
Reach us by sending a text

Jun 8, 2020 • 14min
Ep. 9 - IPOs, Vaccines & BIO's New Leader
Reach us by sending a text

Jun 1, 2020 • 13min
Ep. 8 - Financing Flurry & Purchasing Pools
Reach us by sending a text

May 27, 2020 • 16min
Ep. 7 - FDA takes on COVID-19, plus ASCO's breakthroughs
Reach us by sending a text

May 19, 2020 • 18min
Ep. 6 - New Faces for COVID-19’s Next Phase, ASCO’s Hot Topics
Reach us by sending a text

May 12, 2020 • 15min
Ep. 5 - Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19
Reach us by sending a text

May 5, 2020 • 16min
Ep. 4 - End of the beginning for vaccines and the post-pandemic future
BioCentury editors discuss Goldilocks COVID-19 antibody test regulation, vaccine development, and the post-pandemic future.Reach us by sending a text

Apr 28, 2020 • 15min
Ep. 3 - Surveying the Landscape for Biopharmas
BioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Commissioner Hahn told BioCentury last week.Reach us by sending a text

Apr 23, 2020 • 15min
Ep. 2 - Consorting to beat COVID-19
How industry, government and academics are joining together to discover, develop and deploy therapies and vaccines.Reach us by sending a text

Apr 22, 2020 • 16min
Ep. 1 - Racing to Create Countermeasures
It has been three months since Chinese scientists revealed the genomic sequence of SARS-CoV-2. In our first episode, “Racing to Create Countermeasures,” BioCentury’s editors discuss progress made by biopharma companies and other researchers in developing diagnostics, therapies and vaccines against the virus that causes COVID-19.Reach us by sending a text